ArticleCancers2025

Targeting HER2-Positive Solid Tumors with CAR NK Cells: CD44 Expression Is a Critical Modulator of HER2-Specific CAR NK Cell Efficacy.

Bence Gergely et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.